In this regard, adrenaline showed to activate NF-kB signaling in CRC cells, increasing the expression of miR-155, which, in turn, favored cell proliferation and reduced sensitivity to cisplatin [110], corroborating the potential of catecholamines in endowing resistance to CRC. This evidence concerns the gene NFKB1 and colorectal carcinoma.